Prognostic Value of Right Ventricular Function Assessment by Echocardiography in End-Stage Renal Disease Patients on Maintenance Hemodialysis in Myanmar: A Prospective Observational Cohort Study
Main Article Content
Abstract
Background Cardiovascular disease is the leading cause of mortality among End-Stage Renal Disease (ESRD) patients in Southeast Asia. While left ventricular function is routinely assessed, the prognostic significance of right ventricular (RV) dysfunction remains critically understudied in Myanmar.
Objectives To determine the prevalence of RV dysfunction in maintenance hemodialysis patients and evaluate its independent association with a composite risk of one-year all-cause mortality and cardiovascular hospitalization.
Methods This prospective observational cohort study enrolled 200 adult ESRD patients. To minimize volume loading artifacts, comprehensive post-dialysis transthoracic echocardiography was performed. RV function was assessed using Tricuspid Annular Plane Systolic Excursion (TAPSE), RV Fractional Area Change, and Tissue Doppler Systolic Velocity. The primary composite endpoint evaluated 12-month all-cause mortality and decompensated heart failure hospitalization.
Results The cohort (mean age 53.1±12.4 years; 62% male) exhibited a 41.3% prevalence of RV dysfunction (TAPSE < 17 mm). Over a 12-month median follow-up, the primary endpoint occurred in 26.7% of patients. Non-survivors presented with significantly lower TAPSE (13.8±3.1 vs. 18.9±4.2 mm, p<0.001) and serum albumin. Kaplan-Meier analysis indicated significantly reduced event-free survival for patients with RV dysfunction (p<0.001). Following multivariable Cox regression adjustment for age, LVEF, dialysis vintage, and nutritional status, TAPSE < 17 mm remained a strong independent predictor of the composite outcome (HR: 2.38; 95% CI: 1.55-3.72; p<0.001).
Conclusions Despite overall mortality being lower than historical national averages, RV dysfunction was an independent predictor of adverse cardiovascular outcomes in this optimized hemodialysis cohort.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Makmun A, Satirapoj B, Tuyen DG, Foo MWY, Danguilan R, Gulati S. The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions. Kidney Res Clin Pract. 2025;44(3):411-33.
II. Naramura T, Hyodo T, Kokubo K, Matsubara H, Wakai H, Nakajima F. Dialysis and quality of dialysate in southeast asian developing countries. Nephron Extra. 2014;4(1):64-69.
III. Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118(3):c269-c277.
IV. Tanasa A, Burlacu AA-O, Popa IA-O, Covic A. Right Ventricular Functionality Following Hemodialysis Initiation in End-Stage Kidney Disease-A Single-Center, Prospective, Cohort Study. Medicina. 2021;57(7):704.
V. Myo PM, Zaw H, Thu AK, Oo SM. The Structural and Functional Echocardiographic Changes in Haemodialysis Patients with Chronic Kidney Disease: A Cross-Sectional Study. Int J Med Sci Clin Res Stud. 2025;5(09):1515-23.
VI. Lullo LD, Floccari F, Polito P. Right ventricular diastolic function in dialysis patients could be affected by vascular access. Nephron Clin Pract. 2011;118(3):c257-c261.
VII. Lekawanvijit S, Kompa AR, Manabe M, et al. Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS One. 2012;7(7):e41281.
VIII. Garikapati K, Goh D, Echampati K, Khanna S. Uraemic Cardiomyopathy: A Review of Current Literature. Clin Med Insights Cardiol. 2021;15.
IX. Rambod M, Bross R, Zitterkoph J, et al. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis. 2009;53:298-309.
X. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42:864-81.
XI. Oo ZZ, Oo YT, Than MM, Oo KZ, Wun M, Htun KS. Current Status of Research Ethics Capacity in Myanmar. Asian Bioeth Rev. 2018;10:123-32.
XII. Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251-1263.
XIII. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685-713.
XIV. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233-271.
XV. Alkhouli M, Sandhu P, Boobes K, Hatahet K, Raza F, Boobes Y. Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease. Nefrologia. 2015;35:234-245.
XVI. Ünlü S, Şahinarslan A, Gökalp G, et al. The impact of volume overload on right heart function in end-stage renal disease patients on hemodialysis. Echocardiography. 2018;35(3):314-321.
XVII. Oo SM, Myo PM, Thu AK, Zaw H, Oo TN, Zaw M. The Arrhythmias in End-Stage Renal Disease on Maintenance Haemodialysis: A Cross-Sectional Study. Int J Med Sci Clin Res Stud. 2025;5(10):1700-1707.
XVIII. Turner ME, Beck L, Hill Gallant KM, et al. Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications. Arterioscler Thromb Vasc Biol. 2024;44:584-602.
XIX. Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014;307:891-900.
XX. Peng W, Li Z, Xu H, et al. Assessment of right ventricular dysfunction in end-stage renal disease patients on maintenance haemodialysis by cardiac magnetic resonance imaging. Eur J Radiol. 2018;102:89-94.